ING GROEP NV: FYBR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ING GROEP NV on FYBR, newest first. How the timeline and the estimate are built.
ING GROEP NV held 0 FYBR shares at 2026-03-31 per its 13F-HR filed 2026-05-11.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -228,200 shares
13F-HR 0001140361-26-020394 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 228,200 sharesChange vs previous 13F -7,200 shares
0.05% of the 13F portfolio, value $8,687,574.
13F-HR 0001140361-26-004715 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 235,400 sharesChange vs previous 13F +180,000 shares
0.05% of the 13F portfolio, value $8,792,190.
13F-HR 0001140361-25-040700 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 55,400 sharesChange vs previous 13F +55,400 shares
0.01% of the 13F portfolio, value $2,016,560.
13F-HR 0001140361-25-029070 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -58,800 shares
13F-HR 0001140361-25-018075 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 58,800 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $2,040,360.
13F-HR 0001140361-25-002810 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).